Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Academic / research · Norway
Declared costs: not declared · in the register since 2023
NGO · Belgium
Declared costs: €1M+ a year · in the register since 2011
European Biotech Act · European strategy on research and technology infrastructures
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
NORCE · filed 11 Jun 2025 · source
The Biotechnology and Circular Economy Department at NORCE welcomes the European Commissions initiative to grow the EU biotechnology sector while upholding safety and biosecurity. Drawing on our research and Norways thematic priorities in the next framework programme for R&I priorities in biotechnology, sustainable (aqua)feed, and circular economy, we offer the following input: a) Infrastructure for Innovation The…
European Cancer Organisation · filed 4 Aug 2026 · source
The European Cancer Organisation welcomes the European Commissions proposal for a Biotech Act. The Act shows strong potential in supporting an environment in Europe in which research and innovation in fields such as new cancer treatments can flourish. The Act also identifies a number of barriers to the adoption of improved forms of treatment, with sensible proposals for how these can be alleviated.
NORCE · filed 22 May 2025 · source
Introduction, The sustainability of pan-European research infrastructures as prioritized by the European Strategy Forum on Research Infrastructures (ESFRI) remains a challenge, as does keeping the EUs leading position vis-à-vis our competitors. We agree ito the overall problem definition entailed in the European Strategy on Research and Technology Infrastructures initiative.
European Cancer Organisation · filed 22 May 2025 · source
The European Cancer Organisation (ECO) welcomes the opportunity to provide input on the future of research and technology infrastructures in Europe. Building and sustaining high-performing, interoperable infrastructures is vital for enabling equitable progress in cancer research and innovation, leading to improved patient outcomes across the European Union.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.